surpass tirzepatide Joanne Fagg on X: "$LLY says #semaglutide Sustain-1 $NVO most comparable trial for upcoming #tirzepatide Surpass-1 data https://t.co/ez2gknq0yS" / X surmount trial tirzepatide SURMOUNT-1 SURPASS

Gallbladder Issues : Rapid weight loss can increase gallstone formation

A flurry of NPD mostly in the form of mini ready meals has hit shelves in the past month alone

Clinical Trial Dosing Ranges Dose Titration Schedules Clinical trials have employed gradual dose escalation to minimize gastrointestinal side effects [9] : Standard Titration Protocol (Example from ONWARDS 1) Rationale: Gradual titration allows tolerance development to gastrointestinal effects (particularly nausea) while building up to therapeutic doses

The new discoveries concerning GLP-1 action on the mesolimbic reward system significantly extend the potential therapeutic range of this drug target